These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34260956)
1. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity! Núñez-Zapata SF; Benites-Peralta B; Mayta-Tristan P; Rodríguez-Morales AJ Int J Infect Dis; 2021 Aug; 109():244-246. PubMed ID: 34260956 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand? Haq M; Rehman A; Ahmad J; Zafar U; Ahmed S; Khan MA; Naveed A; Rajab H; Muhammad F; Naushad W; Aman M; Rehman HU; Ahmad S; Anwar S; Haq NU Infection; 2021 Oct; 49(5):983-988. PubMed ID: 34032997 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey. Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464 [TBL] [Abstract][Full Text] [Related]
5. Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão. Silva AAMD; Lima-Neto LG; Azevedo CMPES; Costa LMMD; Bragança MLBM; Barros Filho AKD; Wittlin BB; Souza BF; Oliveira BLCA; Carvalho CA; Thomaz EBAF; Simões-Neto EA; Leite Júnior JF; Cosme LMSS; Campos MAG; Queiroz RCS; Costa SS; Carvalho VA; Simões VMF; Alves MTSSBE; Santos AMD Rev Saude Publica; 2020; 54():131. PubMed ID: 33331525 [TBL] [Abstract][Full Text] [Related]
6. Dengue and COVID-19 Co-Circulation in the Peruvian Amazon: A Population-Based Study. Pons MJ; Mayanga-Herrera A; Ulloa GM; Ymaña B; Medina S; Alava F; Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Rodríguez-Ferrucci H; Morrison AC; Quispe AM Am J Trop Med Hyg; 2023 Jun; 108(6):1249-1255. PubMed ID: 37094790 [TBL] [Abstract][Full Text] [Related]
8. Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil. de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Grespan R; de Souza Siqueira Quintans J; Dos Santos DM; da Silva DN; de Oliveira YLM; de Franca MNF; da Conceição Silva M; de Sá DLF; de Carvalho FO; de Souza MF; de Oliveira Góes MA; Santos VS; Martins-Filho PR Pathog Glob Health; 2023 Jul; 117(5):505-512. PubMed ID: 36094065 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19. Zaidi S; Rizwan F; Riaz Q; Siddiqui A; Khawaja S; Imam M; Naz A; Waheed S; Shamsi T J Public Health (Oxf); 2021 Apr; 43(1):3-8. PubMed ID: 32940328 [TBL] [Abstract][Full Text] [Related]
10. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil. Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142 [TBL] [Abstract][Full Text] [Related]
11. High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious? Signorelli C; Zucchi A; Tersalvi CA; Ciampichini R; Beato E; Balzarini F; Odone A; Middleton J Int J Public Health; 2020 Dec; 65(9):1815-1817. PubMed ID: 33216153 [No Abstract] [Full Text] [Related]
12. [Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic]. Popova AY; Smirnov VS; Ezhlova EB; Mel'nikova AA; Samoilova LV; Lyalina LV; Semenova EV; Gurskiy MA; Aksenova EA; Arbuzova TV; Totolian AA Vopr Virusol; 2021 Sep; 66(4):299-309. PubMed ID: 34545722 [TBL] [Abstract][Full Text] [Related]
13. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD; PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774 [TBL] [Abstract][Full Text] [Related]
15. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. COVID-19 Cumulative Infection Collaborators Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084 [TBL] [Abstract][Full Text] [Related]
16. Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study. Nah EH; Cho S; Park H; Hwang I; Cho HI BMJ Open; 2021 Apr; 11(4):e049837. PubMed ID: 33895722 [TBL] [Abstract][Full Text] [Related]
17. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia. Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis. Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851 [TBL] [Abstract][Full Text] [Related]
19. Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2. Fiore JR; Centra M; De Carlo A; Granato T; Rosa A; Sarno M; De Feo L; Di Stefano M; Errico M; Caputo SL; De Nittis R; Arena F; Corso G; Margaglione M; Santantonio TA J Med Virol; 2021 Mar; 93(3):1739-1742. PubMed ID: 32790086 [TBL] [Abstract][Full Text] [Related]